Protocol for an observational cohort study investigating personalised medicine for intensification of treatment in people with type 2 diabetes mellitus: the PERMIT study

• Samantha Wilkinson,
• Laurie A Tomlinson,
• Amanda I Adler,
• Ian J Douglas,
• Andrew Briggs,
• Richard Grieve,
• Stephen O’neill,
• Richard J Silverwood,
• Paul Charlton,
• Patrick Bidulka,
• Anirban Basu

Affiliations

Samantha Wilkinson

Personalized Healthcare Data Science, Roche Products Limited, Welwyn Garden City, UK

Laurie A Tomlinson

Department of Non-Communicable Disease Epidemiology, London School of Hygiene and Tropical Medicine, London, UK

Amanda I Adler

Diabetes Trials Unit, The Oxford Centre for Diabetes, Endocrinology and Metabolism, University of Oxford, Oxford, UK

Ian J Douglas

Department of Non-Communicable Disease Epidemiology, London School of Hygiene and Tropical Medicine, London, UK

Andrew Briggs

Department of Health Services Research and Policy, London School of Hygiene and Tropical Medicine, London, UK

Richard Grieve

Department of Health Services Research and Policy, London School of Hygiene and Tropical Medicine, London, UK

Stephen O’neill

Department of Health Services Research and Policy, London School of Hygiene and Tropical Medicine, London, UK

Richard J Silverwood

Centre for Longitudinal Studies, University College London, London, UK

Paul Charlton

Patient Research Champion Team, National Institute for Health Research, Twickenham, UK

Patrick Bidulka

Department of Non-Communicable Disease Epidemiology, London School of Hygiene and Tropical Medicine, London, UK

Anirban Basu

The Comparative Health Outcomes, Policy & Economics (CHOICE) Institute, University of Washington School of Pharmacy, Seattle, Washington, USA